Turenne Santé

www.turennecapital.com/expertises-regions/sante/presentation

VCMatch tracks Turenne Santé as an investor focused on Healthtech, Biotech, and Medtech companies, Seed and Series A rounds, France, Hauts De France, and Île De France markets, and $30m check sizes. Upload your deck to compare your startup against the full private matching profile.

Check Size

$30m

Stages

Seed, Series A, Growth, Late Stage

Focus Areas

Healthtech, Biotech, Medtech

Geography

France, Hauts-de-France, and Île-de-France

Investment Thesis

Turenne Groupe operates as a professional shareholder accompanying companies at every stage of development through equity financing. Founded in 1999, the firm believes in creating value for both investors and business leaders by providing counsel and proximity throughout the company’s growth journey. Their approach spans the entire value creation chain across multiple investment stages, from innovation to development to capital reconfiguration.

Is Turenne Santé right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Turenne Santé is most relevant for founders raising Seed, Series A, and Growth rounds in Healthtech, Biotech, and Medtech, especially across France, Hauts-de-France, and Île-de-France, with public check-size signals around $30m.

Focus statement

Turenne Groupe finances companies across France through equity investments, with particular expertise in Healthcare, Hospitality, Energy & Environment, and Deeptech & Innovation sectors. The firm manages €2.1 billion in assets under management and supports 300 companies in its portfolio across multiple development stages.

Value Add

Integrated multi-sector expertise with dedicated teams for Healthcare, Hospitality, Energy & Environment, and Deeptech
Strong regional presence across 7 French regions (Hauts-de-France, Île-de-France, Auvergne-Rhône-Alpes, Sud, Sud-Est, Sud-Ouest, Ouest)
Comprehensive value creation support including strategic counsel, network access, M&A assistance, and exit optimization
Family-owned structure with 85 professionals and 70 institutional investors
Active role in medical research through the Béatrice Denys Foundation for Therapeutic Innovation
Long-term partnership approach with average ticket size of €30M